Alberta Health Services is interested in learning about innovations that might be of benefit to our patients and their families, physicians, and AHS staff.
The Innovation and Business Intelligence (IBI) team manages the innovation submission process and facilitates the evidence, testing, trial development, and evaluation of proposed innovations by relevant stakeholders.
We prioritize innovations that:
Q: I have an innovative product - what next?
A: If you are external to AHS and did not use any AHS resources to develop your innovation, you may propose an innovative product or solution to Alberta Health Services by completing our Health Innovation Submission Form. If you are an AHS employee or you developed your innovation at AHS using AHS resources, see FAQ no. 3 below.
We work with key internal stakeholders to determine if your innovation meets a priority need for AHS. If the innovation meets a priority need, our Innovation and Business Intelligence team will work with you and the stakeholders to determine next steps. All innovations received will be catalogued in AHS' database of proposed innovations which can be reviewed ad hoc for innovation that may match emerging priority problems or needs for innovative solutions.
Q: I have an innovative idea or prototype - what can I do?
A: AHS works closely with partners in the innovation space who help innovators and inventors develop and advance good ideas. Our partners have the expertise and are equipped to work with entrepreneurs to help support various aspects of innovation development. For information on funding that supports early stage development and research for innovation contact us at innovation@ahs.ca.
Q: I have developed an innovation at AHS - what next?
A: You may submit your innovation (invention) to Alberta Health Services by completing our Intellectual Property Disclosure Form.
Our Innovation team will work with you and stakeholders to evaluate the technology and propose a path forward. For more information, see our Intellectual Property Toolkit and Intellectual Property FAQ.